You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,680,312


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,680,312
Title: Stable prostaglandin E gels utilizing colloidal silicon dioxide as a gel-forming agent
Abstract:The present invention provides an improved class of stable gels of prostaglandin E compounds prepared from solutions of prostaglandin E compounds in a pharmaceutically acceptable, stabilizing organic solvent, e.g., triacetin, gelled by the addition of colloidal silicon dioxide.
Inventor(s): Johnson; Brian S. (Crawley, GB)
Assignee: The Upjohn Company (Kalamazoo, MI)
Application Number:06/674,357
Patent Claim Types:
see list of patent claims
Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction to U.S. Patents

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. Patents in the United States are governed by the Patent Act (35 U.S. Code), which establishes the criteria for patentability and the process for obtaining a patent[4].

Types of Patents

There are several types of patents, but the most common is the utility patent, which protects functional inventions and has a duration of 20 years from the date of filing. Other types include design patents, which protect ornamental designs, and plant patents, which protect new varieties of asexually reproducing plants[4].

Patent Eligibility and Section 101

To be eligible for a patent, an invention must meet the criteria outlined in Section 101 of the Patent Act. This includes falling within one of the four statutory categories: processes, machines, manufactures, or compositions of matter. Additionally, the invention must not be a judicial exception, such as an abstract idea, natural phenomenon, or law of nature, unless it is integrated into a practical application[4].

The Alice Test

The Alice test, derived from the Supreme Court's decision in Alice Corp. v. CLS Bank International, is a two-step process for determining patent eligibility under Section 101. Step one involves determining whether the claim is directed to a judicial exception. Step two assesses whether the claim elements, both individually and as an ordered combination, transform the judicial exception into a patent-eligible application[4].

Recent USPTO Guidance on AI Patents

The 2024 USPTO guidance update, prompted by Executive Order 14110, aims to clarify the process for determining the patent eligibility of AI-related inventions. Here are some key points:

  • Integration into Practical Application: The update emphasizes evaluating whether a claim integrates a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

  • AI-Assisted Inventions: The guidance clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

  • Incorporation of Recent Case Law: The update integrates recent Federal Circuit decisions, providing up-to-date legal standards and interpretations particularly relevant for AI inventions. This helps promote consistency and clarity in the application of patent eligibility criteria[1].

  • New Examples: The USPTO has introduced new examples (Examples 47-49) specifically tailored to AI technologies. These examples illustrate how claims involving specific applications of AI can meet the eligibility criteria by demonstrating an improvement in computer technology or providing concrete benefits in real-world applications[1].

Example Analysis: AI-Related Claims

Example 47: Artificial Neural Networks

This example focuses on an artificial neural network designed to identify or detect anomalies. It shows how claims involving specific applications of neural networks can meet the eligibility criteria by demonstrating an improvement in computer technology. For instance, if the neural network is applied in a way that enhances the efficiency or accuracy of a computer system, it could be considered patent-eligible[1].

Example 48: Real-World Applications

This example highlights the importance of demonstrating real-world applications of the claimed method or system. For example, a claim involving the use of separated audio components in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments would be considered patent-eligible. This is because it specifies a practical application that provides clear benefits, such as improved accuracy in speech recognition systems[1].

Crafting Patent-Eligible Claims

To craft claims that are likely to be patent-eligible, especially in the context of AI technologies, the following steps are crucial:

  • Specify Practical Applications: Ensure that the claims specify how the abstract idea is applied in a way that provides concrete benefits or solves specific problems in the relevant field.
  • Demonstrate Technological Improvement: Show how the claimed invention offers a concrete technological improvement, such as enhancing the efficiency or accuracy of a computer system.
  • Avoid Routine Data Processing: Claims should go beyond mere data processing steps and include additional elements that transform the abstract idea into a patent-eligible invention[1].

Statistical Insights and Trends

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can be used to analyze trends in patent scope and the dependency relationship between claims, offering insights into how patent claims have evolved over time[3].

Implications for Innovators and Patent Practitioners

The 2024 USPTO guidance update has significant implications for innovators and patent practitioners:

  • Clarity and Consistency: The update provides more tools to evaluate the patentability of an invention and to draft claims that are more likely to avoid Section 101 rejections.
  • AI Integration: It ensures that AI-assisted inventions are treated equally with other technologies, provided there is significant human contribution.
  • Practical Applications: The emphasis on demonstrating real-world applications and technological improvements helps in crafting stronger, more patent-eligible claims[1].

Future of Patent Law and AI

As AI continues to evolve and play a more significant role in innovation, the patent landscape will likely continue to adapt. The integration of recent case law and the provision of new examples tailored to AI technologies are steps towards ensuring that patent law remains relevant and effective in protecting and promoting innovation.

Key Takeaways

  • Patent Eligibility Criteria: Ensure that claims integrate judicial exceptions into practical applications and demonstrate technological improvements.
  • AI-Assisted Inventions: The method of invention development, including AI, does not impact subject matter eligibility.
  • Real-World Applications: Highlighting real-world applications of the claimed method or system is crucial for patent eligibility.
  • Recent Case Law: The guidance integrates recent Federal Circuit decisions to promote consistency and clarity.
  • Statistical Insights: Utilize datasets like the Patent Claims Research Dataset to analyze trends in patent claims.

FAQs

Q: What is the significance of the 2024 USPTO guidance update on AI patents? A: The update clarifies the process for determining the patent eligibility of AI-related inventions, providing more tools for evaluating patentability and drafting claims that avoid Section 101 rejections.

Q: How does the use of AI impact the patentability of an invention? A: The method of invention development, including the use of AI, does not impact subject matter eligibility. The focus remains on the claimed invention itself, ensuring AI-assisted inventions are evaluated equally with other technologies.

Q: What are the key elements to include in patent claims to ensure eligibility? A: Claims should specify practical applications, demonstrate technological improvements, and avoid routine data processing steps.

Q: How do recent Federal Circuit decisions influence the patent eligibility of AI inventions? A: The integration of recent case law provides up-to-date legal standards and interpretations, promoting consistency and clarity in the application of patent eligibility criteria.

Q: What resources are available for analyzing trends in patent claims? A: The USPTO's Patent Claims Research Dataset offers detailed information on claims from U.S. patents and applications, providing insights into trends in patent scope and claim dependency.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov
  3. Patent Claims Research Dataset - USPTO
  4. Patent Law in the United States - BitLaw
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,680,312

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,680,312

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8208322Mar 22, 1982

International Family Members for US Patent 4,680,312

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 3381898 ⤷  Subscribe
Denmark 127883 ⤷  Subscribe
Denmark 167139 ⤷  Subscribe
European Patent Office 0089768 ⤷  Subscribe
Finland 81962 ⤷  Subscribe
Finland 830890 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.